Allogeneic Stem Cell Transplantation Case Conference 2025-2026

---

RSSAAPAACPECMECNESafetyPSRM - Patient Safety/Risk Management

Occurs weekly every Thursday starting on 1/30/2025 at 1:00 PM
Thursday, January 30, 2025, 1:00 PM - 2:00 PM, PCAM 12 South Conference Romm 12-122 & Virtual, Philadelphia, PA

This is a Weekly Case Conference whose primary goal is to provide ongoing educational updates and reviews to our physicians, nurses, PA's, pharmacists, and other professional in hematology, medical oncology and pathology staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series addresses clinical care in transplantation and novel cellular therapies is discussed. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in care.

1. Discuss novel therapies for Graft-versus-host disease (GVHD)
2. Discuss from an interprofessional perspective appropriate candidates for transplant based on many factors including infectious disease risks, comorbidity risks, disease specific risk factors.
3. Describe how to form an outline of new treatment practices that may impact outcomes, and from an interprofessional perspective discuss availabilities of novel clinical trials and outcomes associated with new approaches
4. Describe outcomes after allogeneic stem cell transplantation for patients with refractory AML or advanced MDS.
5. Describe manifestations of immune effector cell toxicities
6. Discuss best practices for long term follow-up and survivorship issues after allogeneic BMT
7. Describe differences and potential risks and benefits associated with different donor choices from an interprofessional perspective with an emphasis on developing a consistent approach to donor selection through systematic evaluation of various options.

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.00 Category 1 credits for completing this activity.

Nurses: This program provides 1.00 NCPD Hours.

ABS MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn 1.00 credits toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

AMA PRA Category 1 Credits™ (1.00 hours), ACPE (1.00 hours), American Academy of Physician Assistants (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours)

Mitigation of Relevant Financial Relationships

Penn Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.

Date	Empty Column	Title
5/15/2025 1:00:00 PM	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/15/2025 5/15/2025 1:00:00 PM 5/15/2025 2:00:00 PM 15 PCAM 12 South Conference Romm 12-122 & Virtual False MM/DD/YYYY	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/15/2025 This is a Weekly Case Conference whose primary goal is to provide ongoing educational updates and reviews to our physicians, nurses, PA's, pharmacists, and other professional in hematology, medical oncology and pathology staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series addresses clinical care in transplantation and novel cellular therapies is discussed. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in care. Objective(s): Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine Faculty Disclosures: Alison W Loren, MD (Nothing to disclose - 04/02/2025) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours), ACPE (1.00 hours), American Academy of Physician Assistants (1.00 hours) Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine
5/22/2025 1:00:00 PM	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/22/2025 5/22/2025 1:00:00 PM 5/22/2025 2:00:00 PM 15 PCAM 12 South Conference Romm 12-122 & Virtual False MM/DD/YYYY	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/22/2025 This is a Weekly Case Conference whose primary goal is to provide ongoing educational updates and reviews to our physicians, nurses, PA's, pharmacists, and other professional in hematology, medical oncology and pathology staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series addresses clinical care in transplantation and novel cellular therapies is discussed. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in care. Objective(s): Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine Faculty Disclosures: Alison W Loren, MD (Nothing to disclose - 04/02/2025) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours), ACPE (1.00 hours), American Academy of Physician Assistants (1.00 hours) Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine
5/29/2025 1:00:00 PM	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/29/2025 5/29/2025 1:00:00 PM 5/29/2025 2:00:00 PM 15 PCAM 12 South Conference Romm 12-122 & Virtual False MM/DD/YYYY	Allogeneic Stem Cell Transplantation Case Conference 2025-2026 - 5/29/2025 This is a Weekly Case Conference whose primary goal is to provide ongoing educational updates and reviews to our physicians, nurses, PA's, pharmacists, and other professional in hematology, medical oncology and pathology staff to ensure that we are all current with the best practices of allogeneic stem cell transplantation. This series addresses clinical care in transplantation and novel cellular therapies is discussed. This series will promote application of the best possible and most up to date therapies and will ensure standardization across our group and minimize variations in care. Objective(s): Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine Faculty Disclosures: Alison W Loren, MD (Nothing to disclose - 04/02/2025) Download Handout Credits: AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours), NCPD Hours (ANCC) (1.00 hours), Patient Safety/Risk Management PSRM (1.00 hours), ACPE (1.00 hours), American Academy of Physician Assistants (1.00 hours) Location: PCAM 12 South Conference Romm 12-122 & Virtual Specialties: INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, PATHOLOGY - Blood Banking/Transfusion Medicine